|
December 19 2002
18th General Meeting of Shareholders
November 29 2002
Lek Obtains Another Approval to Market Co-Amoxiclav in the US Market
November 29 2002
In its Strategic Integration into the Novartis Group, Lek Retains and Consolidates its Identity
November 26 2002
Lek obtains approval to market co-amoxiclav in the US market
November 26 2002
Public Offer Successfully Completed
November 22 2002
Result of the Bid for Purchase of the Shares of Company Lek Pharmaceuticals d.d.
November 21 2002
Novartis successfully completes friendly public offer for Lek, with more than 99% of shares tendered
November 18 2002
Coamoxiclav products
November 12 2002
Lek Shareholders Give their Approval for the Proposed Resolutions
October 30 2002
Threshold for the successful offer reached
October 30 2002
Outstanding sales results
October 22 2002
Lek announces
October 21 2002
Lek announces
October 21 2002
DEAR SHAREHOLDERS
October 18 2002
Omeprazol
October 05 2002
Opinion of the Board of Management of Lek d.d. on the bid forthe purchase of all shares of the Company
October 01 2002
Lek Decides to File an Appeal Against the Temporary Injunction Issued by the Commercial Court of Zagreb
September 30 2002
Lek announces...
September 27 2002
Lek Shareholders did not Approve the Proposed Modifications to the Statute
August 29 2002
Novartis announces intention to make a public tender offer for the shares of Lek, creating a winning combination in the fast-growing generics market
August 28 2002
Statement for the General Public
August 14 2002
Lendava WWTP Signs Concession Agreement with Lendava Municipality
August 05 2002
Lek's Semiannual Sales Results
July 15 2002
Lek d. d. Successfully Completes Third FDA Inspection in Two Years
July 08 2002
The Foundation Stone of Lek's new Production Plant in Romania
July 02 2002
Lek introduces Lisinopril in the US market
June 28 2002
Lek's Shareholders Supported all the Proposed Decisions
June 26 2002
Lek Donates a New Fire Engine to the Prevalje Fire Brigade
June 06 2002
In Conformity with the Stock Exchange Rules, Lek d. d. as an Issuer of Securities Hereby Informs the Public
May 06 2002
Lek's new Research Center in Slovenia - Progressing toward Greater Innovation
April 24 2002
The Open House in Lendava
April 08 2002
Lek ranks First on the Ljubljana Stock Exchange
March 27 2002
Lek Officially Opens its Renovated Plant for the Manufacture of Sterile Products
March 27 2002
Lek Pleased with Business Operations in 2001
January 28 2002
Lek on the American Market with Bromocriptine Mesylate
January 28 2002
Lek Exceeded Projected Goals in 2001
January 23 2002
The Independent Lek Kozmetika has Ambitious Plans
January 14 2002
Promotions to Managing Directors
 |
